SkinBioTherapeutics plc

4.75pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:SBTXHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (8.63%)
Div yield —
ROE (7.32%)
Biotechnology
Beta (5Y) 0.08
PE TTM —
TSR TTM (70.54%)
Mkt cap £12.31M
ROIC (9.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
5.78p
21.61%
(20.62%)
Hold 7|3|6|6|9
2Q26
3Q26
4Q26
1Q27
Earnings per share£
0.09
0.08
0.09
0.09
26.48%
18.90%
11.45%
5.32%
Revenue£M
1.240
1.238
1.267
1.323
13.71%
9.04%
12.55%
11.73%
Peers (US$17.44M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.344
0.363
0.329
EBIT/Intx
1.308
0.328
0.297
Own earn%
96.48
31.87
26.89
Sh yield%
44.63
6.90
9.40
Owners
Insiders/Inst%
6.08
65.77
Short interest%
5.81
SBC / revenue%
5.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
18–20
$1 testx
—
Incr. ROIC%
1